The DOI matches its Crossref record; 349 of the 349 references it cites were found in a registry or an index.
Anticancer and carcinogenic properties of curcumin: Considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent
Abstract
A growing body of research suggests that curcumin, the major active constituent of the dietary spice turmeric, has potential for the prevention and therapy of cancer. Preclinical data have shown that curcumin can both inhibit the formation of tumors in animal models of carcinogenesis and act on a variety of molecular targets involved in cancer development. In vitro studies have demonstrated that curcumin is an efficient inducer of apoptosis and some degree of selectivity for cancer cells has been observed. Clinical trials have revealed that curcumin is well tolerated and may produce antitumor effects in people with precancerous lesions or who are at a high risk for developing cancer. This seems to indicate that curcumin is a pharmacologically safe agent that may be used in cancer chemoprevention and therapy. Both in vitro and in vivo studies have shown, however, that curcumin may produce toxic and carcinogenic effects under specific conditions. Curcumin may also alter the effectiveness of radiotherapy and chemotherapy. This review article analyzes the in vitro and in vivo cancer-related activities of curcumin and discusses that they are linked to its known antioxidant and pro-oxidant properties. Several considerations that may help develop curcumin as an anticancer agent are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Wang, Z., Zhang, Y., Banerjee, S., Li, Y., & Sarkar, F. H. (2006) · Cancer · doi:10.1002/cncr.21904 · Cited by 263
RetractedAggarwal, B. B., Banerjee, S., Bharadwaj, U., Sung, B., Shishodia, S., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.12.010 · Cited by 153
RetractedHirpara, J. L., Clement, M., & Pervaiz, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004687200 · Cited by 145
RetractedTomita, M., Kawakami, H., Uchihara, J., Okudaira, T., Masuda, M., Takasu, N., Matsuda, T., Ohta, T., Tanaka, Y., Ohshiro, K., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21389 · Cited by 85
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Cited by
A Review on the Dietary Flavonoid Kaempferol
M. Calderon-Montano, J., Burgos-Moron, E., Perez-Guerrero, C., & Lopez-Lazaro, M. (2011) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711795305335 · Cited by 1,383
Naksuriya, O., Okonogi, S., Schiffelers, R. M., & Hennink, W. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.090 · Cited by 841
Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities
Wondrak, G. T. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2541 · Cited by 462
Anti-cancer natural products isolated from chinese medicinal herbs
Tan, W., Lu, J., Huang, M., Li, Y., Chen, M., Wu, G., Gong, J., Zhong, Z., Xu, Z., Dang, Y., et al. (2011) · Chinese Medicine · doi:10.1186/1749-8546-6-27 · Cited by 396
Burgos‐Morón, E., Calderón‐Montaño, J. M., Salvador, J., Robles, A., & López‐Lázaro, M. (2010) · International Journal of Cancer · doi:10.1002/ijc.24967 · Cited by 336
Self-citationSpices for Prevention and Treatment of Cancers
Zheng, J., Zhou, Y., Li, Y., Xu, D.-P., Li, S., & Li, H.-B. (2016) · Nutrients · doi:10.3390/nu8080495 · Cited by 329
Curcumin: An age-old anti-inflammatory and anti-neoplastic agent
Fadus, M. C., Lau, C., Bikhchandani, J., & Lynch, H. T. (2017) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2016.08.002 · Cited by 318
A Review of Therapeutic Effects of Curcumin
Noorafshan, A., & Ashkani-Esfahani, S. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805289273 · Cited by 317
Srivastava, R. A. K., Pinkosky, S. L., Filippov, S., Hanselman, J. C., Cramer, C. T., & Newton, R. S. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r025882 · Cited by 296
Applications of food color and bio-preservatives in the food and its effect on the human health
Dey, S., & Nagababu, B. H. (2022) · Food Chemistry Advances · doi:10.1016/j.focha.2022.100019 · Cited by 296
Nanotechnology-Applied Curcumin for Different Diseases Therapy
Ghalandarlaki, N., Alizadeh, A. M., & Ashkani-Esfahani, S. (2014) · BioMed Research International · doi:10.1155/2014/394264 · Cited by 288
Curcumin uptake and metabolism
Metzler, M., Pfeiffer, E., Schulz, S. I., & Dempe, J. S. (2013) · BioFactors · doi:10.1002/biof.1042 · Cited by 268
De Rossi, L., Rocchetti, G., Lucini, L., & Rebecchi, A. (2025) · Antioxidants · doi:10.3390/antiox14020200 · Cited by 265
Wahlang, B., Pawar, Y. B., & Bansal, A. K. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.006 · Cited by 259
Long, Y., Zhang, W., Wang, F., & Chen, Z. (2014) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2013.10.002 · Cited by 53
Metadata
- Authors
- López-Lázaro, M.
- Venue
- Molecular Nutrition & Food Research
- Publisher
- Wiley
- Published
- 2008-05-21
- Volume
- 52 Suppl 1
- Pages
- S103-27
- ISSN
- 1613-4125 (ISSN-L)
- 1613-4133
- OpenAlex
- W2015833166
- Cited by
- 389
- References
- 349
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.